Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients-Reference-Cited by-同舟云学术

Randomized Controlled Trial of Paliperidone Extended Release Versus Risperidone for the Treatment of Methamphetamine-Associated Psychosis in Chinese Patients

Published:2020-04-01 Issue: Volume:11 Page:
ISSN:1664-0640
Container-title:Frontiers in Psychiatry
language:
Short-container-title:Front. Psychiatry

Author:

Wang Gang,Ding Fan,Chawarski Marek Cezary,Hao Wei,Liu Xuebing,Deng Qijian,Ouyang Xuan

Publisher

Frontiers Media SA

Subject

Psychiatry and Mental health

Reference33 articles.

1. Annual Report on Drug Control in China (2010-2017)

2. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study;Whiteford;Lancet,2013

3. The scourge of methamphetamine: impact on a level I trauma center;Swanson;J Trauma,2007

4. Hostility among methamphetamine users experiencing psychotic symptoms;McKetin;Am J Addict,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Treatments for Methamphetamine Use Disorder: Current Status and Future Targets;Substance Abuse and Rehabilitation;2024-08

2. A Narrative Review of the Pathophysiology and Treatment of Methamphetamine-Associated Psychosis;International Journal of Mental Health and Addiction;2024-05-14

3. Efficacy of probiotic supplements in improving the symptoms of psychosis, anxiety, insomnia, and anorexia due to amphetamine and methamphetamine use: a randomized clinical trial;Psychopharmacology;2024-03-21

4. Pharmacological strategies for sexual recovery in men undergoing antipsychotic treatment;Expert Opinion on Pharmacotherapy;2022-05-01

5. Methamphetamine exposure increases cardiac microvascular permeability by activating the VEGF-PI3K-Akt-eNOS signaling pathway, reversed by Bevacizumab;Human & Experimental Toxicology;2022-01